Filter
88
Text search:
GMP
Featured
Recommendations
13
New Publications
29
Language
Document type
No document type
47
Guidelines
17
Studies & Reports
9
Manuals
8
Strategic & Response Plan
4
Fact sheets
2
Training Material
1
Countries / Regions
Ghana
4
Nepal
4
Kenya
4
Uganda
3
Zimbabwe
3
Botswana
3
Sierra Leone
2
Nigeria
2
Ethiopia
2
Zambia
2
Tanzania
2
South Africa
2
Bangladesh
2
Namibia
2
Western and Central Europe
2
Eastern Europe
2
Global
2
Mali
1
Philippines
1
India
1
Jordan
1
Rwanda
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Latin America and the Carribbean
1
Africa
1
Iran
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
40
Clinical Guidelines
13
Pharmacy & Technologies
8
Public Health
6
Key Resources
5
Women & Child Health
3
Capacity Building
2
Toolboxes
AMR
12
Malaria
10
Pharmacy
9
TB
3
COVID-19
3
Planetary Health
3
Natural Hazards
2
Zika
2
Polio
1
Caregiver
1
2.0 Rapid Response
1
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
Drug Advisory Board
“Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. Some of the vector control interventions deployed in complex emergencies and in response to natural disasters – namely insecticide-treated nets (ITNs) and indoo
...
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch
...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M
...
Effective malaria prevention is threatened by widespread and increasing vector insecticide resistance. Failure to mitigate this threat will likely result in an increased burden of disease, with significant cost implications. This new framework provides support for the development of a national insec
...
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
